ArticleJTO clinical and research reports2021
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With
Keunchil Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleJTO clinical and research reports2021
Keunchil Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.